Back to search

University of Ioannina

Human iPSCs-derived 2D and 3D models to study mTOR signalling in health and disease

Abstract

dc:description

The groundbreaking technology of induced pluripotent stem cells (iPSCs), made by Yamanaka and his team in 2006 and 2007, is a method of reprograming adult cells into a stem-cell-like state. iPSC maintain the ability of self-renewal and differentiation in all of the three germ layers, rendering them highly appealing for application in regenerative medicine, drug screening, cell therapy, and disease modeling. Numerous protocols have been published for the generation of two-dimensional (2D) or three-dimensional (3D) cultures, that recapitulate mature cell types, tissues and organs including specific brain regions. This dissertation is devoted in modeling two of the most common neurodevelopmental and neurodegenerative diseases, Autism Spectrum disorder (ASD) and Parkinson’s disease (PD) respectively, and elucidate their correlation with the regulation and expression of mechanistic target of rapamycin (mTOR). mTOR is a 298 kDa serine/threonine kinase that is a part of the phosphatidylinositol 3-kinase (PI3K) related family with two divergent complexes, mTOR Complex 1 (mTORC1) and 2 (mTORC2). mTOR controls cell growth, nutrient metabolism, and protein synthesis which are altered in ASD and PD.An overarching theme in both experimental chapters of this thesis is the development and characterization of 2D and 3D models, derived from human iPSC in order to test the central thesis hypothesis. While this thesis is being composed, the UK has become the first country to set firm deadlines for phasing out animal testing, committing to shift entire regulatory endpoints to validated human-relevant methods by 2027 and accelerating a broader transatlantic move toward New Approach Methodologies (NAMs). These developments signal a rapid, coordinated shift in preclinical science from “replace where possible” to “replace on schedule,” with major investments, regulatory momentum, and international alignment already underway. The first part of the present thesis is dedicated to establishing human cerebral organoid and cortical neuron models derived from iPSCs with targeted genome editing to abolish protein expression of the CNTNAP2 gene, associated with ASD. The cerebral organoid model is used to study genetic pathways in early development that are involved in the polygenic nature of ASD. CNTNAP2 KO organoids displayed significant reduction in size at D30, accelerated cell cycle, increased surface folding and ventricular zone (VZ) disorganization. Proteomics analysis revealed disruption in excitatory and inhibitory synaptic pathways, as well as in neurodevelopment, while bulk RNA-seq revealed differentially expressed genes belonging to inhibitory neuron-related gene networks. Interestingly, there was a weak correlation between those datasets, suggesting nuanced translational control mechanisms, and highlighting the crucial role of AKT/mTOR pathway which was upregulated in CNTNAP2 KO organoids. Omics analyses also identified forkhead box G1 (FOXG1) as a top target involved in the development of cortical interneurons. Consistent with this, our model of CNTNAP2 KO organoids showed increased differentiation of gamma-aminobutyric acidergic (GABAergic) interneuron. These findings clarify the role of CNTNAP2 and mTOR pathway in ASD pathophysiology and early cortical development and pave the way for the development of targeted therapies employing cerebral organoids as preclinical models. The second part of this thesis focuses on investigating early pathological mechanisms associated with SNCA gene triplication and subsequent synucleinopathies, and their link to proteostasis, using iPSC derived midbrain organoids carrying an SNCA triplication. SNCA triplication organoids exhibited increased α-synuclein accumulation, neuromelanin deposition, reduction in diameter and projected area at D100. Moreover, they presented activation of mTORC1 (phospho-ribosomal protein S6; rpS6), ERK1/2, AKT and eukaryotic initiation factor 2 alpha (eIF2α) signalling pathways by D100. Proteomic analyses identified upregulation in proteins involved in axonal, cytoskeletal and synaptic development pathways and downregulation in extracellular matrix (ECM) components, such as laminin. Transcriptomics corroborated these findings by showing significant downregulation in the expression of ECM related mRNAs and upregulation of mRNAs encoding for proteins abundant in the perineuronal nets (PNNs). Bulk translatomics of actively translated mRNAs measured by Ribosome profiling revealed modest changes in global translation but uncovered selective translational buffering of neuronal and ECM-associated transcripts. Confocal imaging was utilized to examine the organization of ECM at cellular level and confirmed pronounced enrichment of pericellular and interstitial ECM structure around neurons in SNCA triplication organoids. Interestingly, this phenotype appeared earlier in tyrosine hydroxylase (TH+) neurons compared to microtubule associated protein 2 (MAP2+) cells. An attempt was made to elucidate whether ECM remodeling acts as a neuroprotective or neurodegenerative mechanism through pharmacological inhibition of the ECM, however the results were inconclusive. Dopaminergic neurons were also generated and characterized, but neuronal cultures derived from SNCA Trip iPSCs proved non-viable. All these findings revealed that SNCA triplication induces proteostatic disruption and ECM remodelling prior to neurodegeneration and suggest that altered gene expression and ECM homeostasis may contribute to disease initiation and progression. Targeting these early aberrant mechanisms may offer new therapeutic opportunities for synucleinopathies, such as Parkinson’s disease.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Statoulla, Elpida
  • Στάτουλλα, Ελπίδα

Subjects

dc:subject × 21

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60616

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Statoulla, Elpida; Στάτουλλα, Ελπίδα. Human iPSCs-derived 2D and 3D models to study mTOR signalling in health and disease. University of Ioannina, 2025. http://hdl.handle.net/10442/hedi/60616